产品名称 | NebuSelect™ Recombinant Human PGF, hFc-tag |
---|---|
目录号 | NBL-242198 |
别名 | PGF; PlGF; PGF; PGFL; SHGC-10760; D12S1900; PlGF-2 |
外观 | see COA |
分子量 | Leu19-Arg221 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P49763-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242198-100ug | 100ug | Inquire | Inquire | |
NBL-242198-1mg | 1mg | Inquire | Inquire | |
NBL-242198-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human PGF, hFc-tag
Catalog#:
NBL-242198
Description:
NebuSelect™ Recombinant Human PGF, hFc-tag(Cat#NBL-242198) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Leu19-Arg221.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 48.6 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Target Name:
PGF; PlGF; PGF; PGFL; SHGC-10760; D12S1900; PlGF-2
Target Information:
Placental growth factor (PGF) is another member of the VEGF family of cytokines with pro-angiogenic and pro-inflammatory effects. Retinal inhibition of PGF in combination with VEGF-A prevents vascular leakage and CNV possibly via modulating their own expression in mononuclear phagocytes. PGF-related, optimized strategies to target inflammation-mediated angiogenesis may help to increase efficacy and reduce non-responders in the treatment of wet AMD patients.
Amino Acid Sequence:
Leu19-Arg221
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.